Tirzepatide
US$ 21.49
comparison of glp-1 agonists Comparative features glucagon-like peptide 1-receptor GLP-1 RECEPTORS AGONISTS Comparisons among
Description
The challenge is to support innovation while maintaining clinical standards and patient protection
Emmerich SD et al
& Wei, W
Targeted pharmacological therapy restores -cell function for diabetes remission
Currently, there are no approved targeted therapies for LVEF-preserved heart failure associated with obesity
[7] However, the use of GLP-1 agonists during pregnancy and lactation is less well understood, as these groups are typically excluded from clinical trials